相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Model-based meta-analysis of the time to first acute urinary retention or benign prostatic hyperplasia-related surgery in patients with moderate or severe symptoms
Salvatore D'Agate et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Impact of disease progression on individual IPSS trajectories and consequences of immediate versus delayed start of treatment in patients with moderate or severe LUTS associated with BPH
Salvatore D'Agate et al.
WORLD JOURNAL OF UROLOGY (2020)
Model-based meta-analysis of individual International Prostate Symptom Score trajectories in patients with benign prostatic hyperplasia with moderate or severe symptoms
Salvatore D'Agate et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Cognitive and mood side effects of lower urinary tract medication
A. Elif Muderrisoglu et al.
EXPERT OPINION ON DRUG SAFETY (2019)
Comparison of the clinical effect of dutasteride therapy for benign prostatic hyperplasia when initiated at different time points: A multicentre, observational, retrospective chart review study
Yukiko Shima et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2019)
Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): A post hoc analysis of a prospective randomised placebo-controlled study
Raymond C. Rosen et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2019)
Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline
Harris E. Foster et al.
JOURNAL OF UROLOGY (2018)
A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)
Claus G. Roehrborn et al.
BJU INTERNATIONAL (2018)
Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base
Mauro Gacci et al.
THERAPEUTIC ADVANCES IN UROLOGY (2018)
Can Long-term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention?
Fabrizio Presicce et al.
CURRENT UROLOGY REPORTS (2017)
Pharmacological treatment of benign prostatic hyperplasia
M. Oelke et al.
UROLOGE (2016)
Pharmacological treatment of benign prostatic hyperplasia
M. Oelke et al.
UROLOGE (2016)
Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride
Josephina G. Kuiper et al.
BMC UROLOGY (2016)
Efficacy and safety of a fixed-dose combination of dutasteride and tamsulosin treatment (Duodart®) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the management of treatment-naive men with moderately symptomatic benign prostatic hyperplasia: 2-year CONDUCT study results
Claus G. Roehrborn et al.
BJU INTERNATIONAL (2015)
The Impact of Combination Therapy with a-Blockers and 5ARIs on the Progression of BPH
Petros Sountoulides et al.
CURRENT DRUG TARGETS (2015)
Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study
Claus G. Roehrborn et al.
BJU INTERNATIONAL (2014)
Serial Prostate Biopsy and Risk of Lower Urinary Tract Symptoms: Results From a Large, Single-institution Active Surveillance Cohort
Allison S. Glass et al.
UROLOGY (2014)
Clinical Progression, Acute Urinary Retention, Prostate-Related Surgeries, and Costs in Patients with Benign Prostatic Hyperplasia Taking Early Versus Delayed Combination 5α-Reductase Inhibitor Therapy and α-Blocker Therapy: A Retrospective Analysis
Robert Morlock et al.
CLINICAL THERAPEUTICS (2013)
Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score
Tetsuya Fujimura et al.
BJU INTERNATIONAL (2012)
American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: revisited
Armando A. Juliao et al.
CURRENT OPINION IN UROLOGY (2012)
Overview of the Epidemiology Methods and Applications: Strengths and Limitations of Observational Study Designs
Graham A. Colditz
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2010)
The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study
Claus G. Roehrborn et al.
EUROPEAN UROLOGY (2010)
Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery
Michael Naslund et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Washout and delayed start designs for identifying disease modifying effects in slowly progressive diseases using disease progression analysis
Berend Arnold Ploeger et al.
PHARMACEUTICAL STATISTICS (2009)
Association of Sexual Dysfunction With Lower Urinary Tract Symptoms of BPH and BPH Medical Therapies: Results From the BPH Registry
Raymond C. Rosen et al.
UROLOGY (2009)
BPH progression: Concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE
Claus G. Roehrborn
BJU INTERNATIONAL (2008)
The natural history of benign prostatic hyperplasia
JM Fitzpatrick
BJU INTERNATIONAL (2006)
Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six European countries: Report of the TRIUMPH study
NA van Exel et al.
EUROPEAN UROLOGY (2006)
Estimating a treatment effect in survival studies in which patients switch treatment
M Branson et al.
STATISTICS IN MEDICINE (2002)
分享论文
